Intravenous Voriconazole (IV-VORI) Prevents Invasive Fungal Infections (IFI) in Patients (pts) with Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome (MDS).
Year: 2004
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Blood
Institution: The University of Texas MD Anderson Cancer Center
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2586468705
